However, the precise pathophysiological mechanism that link MHA and PFO have not been completely explained [43] but this hypothesis could explain the correlation that some authors found between P2Y12 inhibitors and relief from MHA symptoms [44]. The gene discussed is P2RY12; the disease is macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss.